PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 96 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,000 | -98.0% | 438 | -98.9% | 0.00% | – |
| Q1 2021 | $99,000 | +3.1% | 38,400 | 0.0% | 0.00% | – |
| Q4 2020 | $96,000 | +21.5% | 38,400 | 0.0% | 0.00% | – |
| Q3 2020 | $79,000 | -33.6% | 38,400 | 0.0% | 0.00% | – |
| Q2 2020 | $119,000 | +35.2% | 38,400 | 0.0% | 0.00% | – |
| Q1 2020 | $88,000 | -36.7% | 38,400 | 0.0% | 0.00% | – |
| Q4 2019 | $139,000 | +6.1% | 38,400 | 0.0% | 0.00% | – |
| Q3 2019 | $131,000 | -27.2% | 38,400 | 0.0% | 0.00% | – |
| Q2 2019 | $180,000 | +39.5% | 38,400 | 0.0% | 0.00% | – |
| Q1 2019 | $129,000 | +26.5% | 38,400 | 0.0% | 0.00% | – |
| Q4 2018 | $102,000 | -52.6% | 38,400 | 0.0% | 0.00% | – |
| Q3 2018 | $215,000 | -27.4% | 38,400 | -34.2% | 0.00% | – |
| Q2 2018 | $296,000 | +31.6% | 58,400 | +77.0% | 0.00% | – |
| Q1 2018 | $225,000 | -9.6% | 33,000 | 0.0% | 0.00% | – |
| Q4 2017 | $249,000 | +31.1% | 33,000 | 0.0% | 0.00% | – |
| Q3 2017 | $190,000 | +137.5% | 33,000 | +107.5% | 0.00% | – |
| Q2 2017 | $80,000 | – | 15,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 3,196,527 | $16,526,000 | 3.00% |
| BVF INC/IL | 5,328,239 | $27,547,000 | 1.08% |
| Soleus Capital Management, L.P. | 740,000 | $3,826,000 | 0.60% |
| Cutter & CO Brokerage, Inc. | 326,100 | $1,686,000 | 0.40% |
| EAM Investors, LLC | 288,459 | $1,491,000 | 0.25% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $5,316,000 | 0.15% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,551,000 | 0.11% |
| Navis Wealth Advisors, LLC | 16,000 | $83,000 | 0.06% |
| Sigma Planning Corp | 364,484 | $1,884,000 | 0.06% |
| XTX Topco Ltd | 32,650 | $169,000 | 0.06% |